Eric Scholar

2.4k total citations · 1 hit paper
27 papers, 1.8k citations indexed

About

Eric Scholar is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Eric Scholar has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Eric Scholar's work include Biochemical and Molecular Research (10 papers), Neuropeptides and Animal Physiology (3 papers) and HIV/AIDS drug development and treatment (3 papers). Eric Scholar is often cited by papers focused on Biochemical and Molecular Research (10 papers), Neuropeptides and Animal Physiology (3 papers) and HIV/AIDS drug development and treatment (3 papers). Eric Scholar collaborates with scholars based in United States and Italy. Eric Scholar's co-authors include Amit Arora, James E. Talmadge, Moses Donkor, Peter A. Calabresi, Robert E. Parks, Myron L. Toews, Phyllis R. Brown, William B. Pratt, R. P. Agarwal and Khushboo Agarwal and has published in prestigious journals such as Blood, Cancer and Biochemical and Biophysical Research Communications.

In The Last Decade

Eric Scholar

27 papers receiving 1.7k citations

Hit Papers

Role of Tyrosine Kinase Inhibitors in Cancer Therapy 2005 2026 2012 2019 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Scholar United States 18 893 581 279 222 174 27 1.8k
W. Schüler Switzerland 29 1.0k 1.2× 564 1.0× 992 3.6× 134 0.6× 169 1.0× 68 3.0k
Lou A. Smets Netherlands 32 1.7k 1.9× 566 1.0× 353 1.3× 135 0.6× 211 1.2× 97 2.9k
Glen S. Germain United States 17 986 1.1× 558 1.0× 86 0.3× 191 0.9× 110 0.6× 30 1.6k
Asher Begleiter Canada 31 1.5k 1.6× 496 0.9× 168 0.6× 139 0.6× 494 2.8× 99 2.5k
Wynne Aherne United Kingdom 27 1.5k 1.7× 509 0.9× 157 0.6× 158 0.7× 161 0.9× 58 2.3k
John M. Venditti United States 26 1.1k 1.2× 1.0k 1.7× 166 0.6× 282 1.3× 275 1.6× 91 2.6k
James J. Starling United States 26 1.1k 1.3× 1.3k 2.2× 139 0.5× 160 0.7× 207 1.2× 55 2.2k
Erin R. Gardner United States 25 1.5k 1.7× 1.1k 1.9× 226 0.8× 256 1.2× 133 0.8× 49 2.9k
Ramzi M. Mohammad United States 28 1.1k 1.2× 788 1.4× 177 0.6× 175 0.8× 119 0.7× 74 1.9k
Thomas J. Brown United States 24 651 0.7× 242 0.4× 181 0.6× 127 0.6× 192 1.1× 66 2.6k

Countries citing papers authored by Eric Scholar

Since Specialization
Citations

This map shows the geographic impact of Eric Scholar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Scholar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Scholar more than expected).

Fields of papers citing papers by Eric Scholar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Scholar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Scholar. The network helps show where Eric Scholar may publish in the future.

Co-authorship network of co-authors of Eric Scholar

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Scholar. A scholar is included among the top collaborators of Eric Scholar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Scholar. Eric Scholar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abe, Fuminori, et al.. (2009). Therapeutic activity of sunitinib for Her2/neu induced mammary cancer in FVB mice. International Immunopharmacology. 10(1). 140–145. 21 indexed citations
2.
Abe, Fuminori, Alicia J. Dafferner, Moses Donkor, et al.. (2009). Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice. Cancer Immunology Immunotherapy. 59(1). 47–62. 45 indexed citations
3.
Talmadge, James E., Moses Donkor, & Eric Scholar. (2007). Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer and Metastasis Reviews. 26(3-4). 373–400. 233 indexed citations
4.
Arora, Amit & Eric Scholar. (2005). Role of Tyrosine Kinase Inhibitors in Cancer Therapy. Journal of Pharmacology and Experimental Therapeutics. 315(3). 971–979. 785 indexed citations breakdown →
5.
Scholar, Eric, et al.. (1999). N-linked oligosaccharides and metastatic propensity in in vivo selected mouse mammary adenocarcinoma cells. Clinical & Experimental Metastasis. 17(5). 437–444. 3 indexed citations
6.
Scholar, Eric & Myron L. Toews. (1994). Inhbition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Letters. 87(2). 159–162. 58 indexed citations
7.
Scholar, Eric, et al.. (1991). Stimulation of tumor cell growth by vasoactive intestinal peptide. Cancer. 67(6). 1561–1564. 24 indexed citations
8.
Scholar, Eric, et al.. (1989). The effect of diets enriched in cabbage and collards on Murine pulmonary metastasis. Nutrition and Cancer. 12(2). 121–126. 19 indexed citations
9.
Scholar, Eric, et al.. (1989). The effect of dietary fat on metastasis of the lewis lung carcinoma and the BALB/c mammary carcinoma. Nutrition and Cancer. 12(2). 109–119. 23 indexed citations
10.
Scholar, Eric, et al.. (1987). Nicotinic receptor stimulation enhances enkephalin-like peptides processing in chromaffin cells. Life Sciences. 41(23). 2563–2572. 2 indexed citations
11.
Scholar, Eric, et al.. (1987). The antimetastatic activity of enkephalin-like peptides. Cancer Letters. 35(2). 133–138. 51 indexed citations
12.
Scholar, Eric. (1986). Inhibition of the growth of human lung cancer cells by alkyl-lysophospholipid analogs. Cancer Letters. 33(2). 199–204. 10 indexed citations
13.
Donnelly, Thomas E., et al.. (1985). Relationship between membrane-bound protein kinase C activity and calcium-dependent proliferation of BALBc 3T3 cells. Biochemical and Biophysical Research Communications. 126(2). 741–747. 19 indexed citations
14.
Scholar, Eric & Paul Calabresi. (1979). Increased activity of alkaline phosphatase in leukemic cells from patients resistant to thiopurines. Biochemical Pharmacology. 28(3). 445–446. 12 indexed citations
15.
Crabtree, Gerald W., Eric Scholar, S. Haihua Chu, & Robert E. Parks. (1973). Inhibition of purine biosynthesis de novo in sarcoma 180 ascites cells by mercapto and seleno purine analogs. Biochemical Pharmacology. 22(2). 155–162. 8 indexed citations
16.
Scholar, Eric & Peter A. Calabresi. (1973). Identification of the enzymatic pathways of nucleotide metabolism in human lymphocytes and leukemia cells.. PubMed. 33(1). 94–103. 98 indexed citations
17.
Senft, Alfred W., Gerald W. Crabtree, Kailash C. Agarwal, et al.. (1973). Pathways of nucleotide metabolism in Schistosoma mansoni—III. Biochemical Pharmacology. 22(4). 449–458. 40 indexed citations
18.
Scholar, Eric, Phyllis R. Brown, Robert E. Parks, & Peter A. Calabresi. (1973). Nucleotide Profiles of the Formed Elements of Human Blood Determined by High-Pressure Liquid Chromatography. Blood. 41(6). 927–936. 63 indexed citations
19.
Scholar, Eric, Phyllis R. Brown, & Robert E. Parks. (1972). Synergistic effect of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside on the levels of adenine nucleotides of Sarcoma 180 cells.. PubMed. 32(2). 259–69. 37 indexed citations
20.
Agarwal, R. P., Eric Scholar, Khushboo Agarwal, & Robert E. Parks. (1971). Identification and isolation on a large scale of guanylate kinase from human erythrocytes. Biochemical Pharmacology. 20(7). 1341–1354. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026